GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Ray Medicine International Holding Ltd (HKSE:06108) » Definitions » Dividend Yield %

New Ray Medicine International Holding (HKSE:06108) Dividend Yield % : 0.00% (As of Jun. 07, 2024)


View and export this data going back to 2013. Start your Free Trial

What is New Ray Medicine International Holding Dividend Yield %?

As of today (2024-06-07), the Trailing Annual Dividend Yield of New Ray Medicine International Holding is 0.00%.

The historical rank and industry rank for New Ray Medicine International Holding's Dividend Yield % or its related term are showing as below:

During the past 12 years, the highest Dividend Yield of New Ray Medicine International Holding was 12.34%. The lowest was 0.00%. And the median was 5.14%.

HKSE:06108's Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.935
* Ranked among companies with meaningful Dividend Yield % only.

New Ray Medicine International Holding's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00.

During the past 12 years, the highest Dividend Payout Ratio of New Ray Medicine International Holding was 0.70. The lowest was 0.70. And the median was 0.70.

As of today (2024-06-07), the Forward Dividend Yield % of New Ray Medicine International Holding is 0.00%.

New Ray Medicine International Holding's Dividends per Share for the six months ended in Dec. 2023 was HK$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


New Ray Medicine International Holding Dividend Yield % Historical Data

The historical data trend for New Ray Medicine International Holding's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Ray Medicine International Holding Dividend Yield % Chart

New Ray Medicine International Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

New Ray Medicine International Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of New Ray Medicine International Holding's Dividend Yield %

For the Pharmaceutical Retailers subindustry, New Ray Medicine International Holding's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Ray Medicine International Holding's Dividend Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, New Ray Medicine International Holding's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where New Ray Medicine International Holding's Dividend Yield % falls into.



New Ray Medicine International Holding Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


New Ray Medicine International Holding  (HKSE:06108) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


New Ray Medicine International Holding Dividend Yield % Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


New Ray Medicine International Holding (HKSE:06108) Business Description

Traded in Other Exchanges
N/A
Address
19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN
New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.
Executives
Dai Xiaosong
Eagle Amber Holdings Limited
Chu Xueping 2201 Interest of corporation controlled by you
Qian Shenglei 2101 Beneficial owner
Zhang Jiang 2201 Interest of corporation controlled by you
Yang Fang 2202 Interest of your spouse
Zhou Ling 2101 Beneficial owner

New Ray Medicine International Holding (HKSE:06108) Headlines

No Headlines